1. Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
   A. P. Tkachuk et al, 2017, PLOS ONE CrossRef
2. Peptide-Based Vaccines for Tuberculosis
   Wenping Gong et al, 2022, Frontiers in Immunology CrossRef
3. The use of adenoviral vectors in gene therapy and vaccine approaches
   Natália Meneses Araújo et al, 2022, Genetics and Molecular Biology CrossRef
4. Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins
   Deepa Paliwal et al, 2022, Frontiers in Molecular Biosciences CrossRef
5. An overview of the BCG vaccine and its future scope
   Pallavi Khandelia et al, 2023, Indian Journal of Tuberculosis CrossRef
6. A review of the BCG vaccine and other approaches toward tuberculosis eradication
   Thomas Cho et al, 2021, Human Vaccines & Immunotherapeutics CrossRef
7. Adenoviral vector-based strategies against infectious disease and cancer
   Chao Zhang et al, 2016, Human Vaccines & Immunotherapeutics CrossRef
8. Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques
   Patricia A. Darrah et al, 2019, npj Vaccines CrossRef
9. Inhaled aerosol viral-vectored vaccines against tuberculosis
   Elena Stylianou et al, 2024, Current Opinion in Virology CrossRef
10. Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying Mycobacterium tuberculosis Antigen Ag85B Enhance Ag85B-Specific Immune Responses in Female C57BL/c Mice
    Fangbin Zhou et al, 2023, Viruses CrossRef
11. Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
    Erkko Ylösmäki et al, 2021, Journal for ImmunoTherapy of Cancer CrossRef
12. Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2
    Cong Peng et al, 2023, Journal of Personalized Medicine CrossRef
13. Chitosan nanoparticles containing fusion protein (Hspx–PPE44–EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis
    Rasul Hoseinpur et al, 2022, Journal of Biomaterials Applications CrossRef
14. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
    Fu-Ying Dai et al, 2017, Human Vaccines & Immunotherapeutics CrossRef
15. The Immunological Impact of Adenovirus Early Genes on Vaccine-Induced Responses in Mice and Nonhuman Primates
    Kotou Sangare et al, 2021, Journal of Virology CrossRef
16. CFP10–loaded PLGA nanoparticles as a booster vaccine confer protective immunity against Mycobacterium bovis
    Zhengmin Liang et al, 2022, BioImpacts CrossRef
17. Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA-hsp65 Tuberculosis Vaccine in Cynomolgus Monkeys
    Monique Ribeiro de Lima et al, 2023, Vaccines CrossRef